Company: BIVIW
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001520138-25-000205
Chunk: 112

Company: BIOVIE INC.
Filing Date: 2025-07-11
Form: S-1/A
Chunk 112
---
 the liability occurs in the principal or most advantageous market for the asset or liability and establishes
that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing
the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input
that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used
to measure fair value:

<div align='center'>58</div>

Level 1 - Inputs are unadjusted quoted prices
in active markets for identical assets or liabilities.

Level 2 - Inputs are quoted prices for similar
assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through
market corroboration, for substantially the full term of the financial instrument.

Level 3 - Inputs are unobservable inputs based
on our assumptions.

New Accounting Pronouncements

The Company considered the applicability and impact
of recent accounting pronouncements and determined those to be either not applicable or expected to have minimal impact on our balance
sheets or statement of operations and comprehensive loss.

<div align='center'>59

MANAGEMENT</div>

Executive Officers

The following table sets forth certain information regarding our executive
officers and directors as of July 11, 2025.

| Name                  |     | Age |     | Director Since |     | Position                     |
| Cuong Do              |     |  59 |     |           2016 |     | CEO & President and Director |
| Joanne Wendy Kim      |     |  70 |     |             -- |     | Chief Financial Officer      |
| Joseph M. Palumbo, MD |     |  64 |     |             -- |     | Chief Medical Officer        |
| Jim Lang              |     |  60 |     |           2016 |     | Chairman of the Board        |
| Sigmund Rogich        |     |  81 |     |           2020 |     | Director                     |
| Michael Sherman       |     |  65 |     |           2017 |     | Director                     |

Mr. Cuong Do has served on the Company’s Board of Directors
since 2016 and effective April 27, 2021 was appointed the Company’s CEO and President. He served as the President, Global Strategy
Group, at Samsung from February 2015 to December 2020. Mr. Do helped